{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:40:07Z","timestamp":1783179607732,"version":"3.54.6"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jns.2019.01.046","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T01:15:07Z","timestamp":1548810907000},"page":"142-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Clinical, neuropsychological and imaging characteristics of Alzheimer's disease patients presenting as corticobasal syndrome"],"prefix":"10.1016","volume":"398","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7432-5009","authenticated-orcid":false,"given":"Vasilios C.","family":"Constantinides","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George P.","family":"Paraskevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthymia","family":"Efthymiopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas","family":"Stefanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Kapaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2019.01.046_bb0005","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.01.046_bb0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1212\/WNL.48.1.119","article-title":"Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study","volume":"48","author":"Litvan","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.01.046_bb0015","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1212\/WNL.48.4.959","article-title":"Corticobasal degeneration: neuropathologic and clinical heterogeneity","volume":"48","author":"Schneider","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.01.046_bb0020","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1212\/WNL.53.4.795","article-title":"Pathologic heterogeneity in clinically diagnosed corticobasal degeneration","volume":"53","author":"Boeve","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.01.046_bb0025","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/mds.22558","article-title":"Is the pathology of corticobasal syndrome predictable in life?","volume":"24","author":"Shelley","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2019.01.046_bb0030","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/brain\/awq123","article-title":"Does corticobasal degeneration exist? A clinicopathological re-evaluation","volume":"133","author":"Ling","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jns.2019.01.046_bb0035","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/jnen\/61.11.935","article-title":"H. Office of Rare Diseases of the National Institutes of, Office of Rare Diseases neuropathologic criteria for corticobasal degeneration","volume":"61","author":"Dickson","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jns.2019.01.046_bb0040","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1212\/WNL.0b013e3181feb2e8","article-title":"Imaging correlates of pathology in corticobasal syndrome","volume":"75","author":"Whitwell","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.01.046_bb0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ana.22424","article-title":"Clinicopathological correlations in corticobasal degeneration","volume":"70","author":"Lee","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2019.01.046_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jns.2019.01.046_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2019.01.046_bb0060","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/jnnp.2010.221853","article-title":"CSF Alzheimer's disease-like pattern in corticobasal syndrome: evidence for a distinct disorder","volume":"82","author":"Borroni","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.01.046_bb0065","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2217\/bmm.12.46","article-title":"Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update","volume":"6","author":"del Campo","year":"2012","journal-title":"Biomark. Med"},{"key":"10.1016\/j.jns.2019.01.046_bb0070","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jns.2017.09.039","article-title":"CSF biomarkers \u03b2-amyloid, tau proteins and a-synuclein in the differential diagnosis of Parkinson-plus syndromes","volume":"382","author":"Constantinides","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2019.01.046_bb0075","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3233\/JAD-160494","article-title":"Cerebrospinal fluid biomarkers as a diagnostic tool of the underlying pathology of primary progressive aphasia","volume":"55","author":"Paraskevas","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jns.2019.01.046_bb0080","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1177\/153331750001500604","article-title":"Mini Mental State Examination (MMSE): a validation study in Greece","volume":"15","author":"Fountoulakis","year":"2000","journal-title":"Am. J. Alzheimers. Dis. Other Demen."},{"key":"10.1016\/j.jns.2019.01.046_bb0085","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/gps.1045","article-title":"Validity and reliablity of the newly translated Hellenic Neuropsychiatric Inventory (H-NPI) applied to Greek outpatients with Alzheimer's disease: a study of disturbing behaviors among referrals to a memory clinic","volume":"19","author":"Politis","year":"2004","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jns.2019.01.046_bb0090","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1093\/cercor\/bhm004","article-title":"Pantomime of tool use depends on integrity of left inferior frontal cortex","volume":"17","author":"Goldenberg","year":"2007","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.jns.2019.01.046_bb0095","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0028-3932(03)00120-9","article-title":"Defective pantomime of object use in left brain damage: apraxia or asymbolia?","volume":"41","author":"Goldenberg","year":"2003","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.jns.2019.01.046_bb0100","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000100973","article-title":"Clinical significance of lobar atrophy in frontotemporal dementia: application of an MRI visual rating scale","volume":"23","author":"Kipps","year":"2007","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.jns.2019.01.046_bb0105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/jnnp.70.2.165","article-title":"Temporal lobe rating scale: application to Alzheimer's disease and frontotemporal dementia","volume":"70","author":"Galton","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.01.046_bb0110","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1007\/s00330-011-2205-4","article-title":"Visual assessment of posterior atrophy development of a MRI rating scale","volume":"21","author":"Koedam","year":"2011","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.jns.2019.01.046_bb0115","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/jnnp.55.10.967","article-title":"Atrophy of medial temporal lobes on MRI in \u201cprobable\u201d Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates","volume":"55","author":"Scheltens","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.01.046_bb0120","first-page":"1","article-title":"Simple linear brainstem MRI measurements in the differential diagnosis of progressive supranuclear palsy from the parkinsonian variant of multiple system atrophy","author":"Constantinides","year":"2017","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jns.2019.01.046_bb0125","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1600-0404.2006.00767.x","article-title":"Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging","volume":"116","author":"Cosottini","year":"2007","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2019.01.046_bb0130","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.neuroimage.2006.05.044","article-title":"Topography of the human corpus callosum revisited\u2014Comprehensive fiber tractography using diffusion tensor magnetic resonance imaging","volume":"32","author":"Hofer","year":"2006","journal-title":"NeuroImage"},{"key":"10.1016\/j.jns.2019.01.046_bb0135","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/mds.22574","article-title":"Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome","volume":"24","author":"Hu","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2019.01.046_bb0140","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/mds.23062","article-title":"Anatomical differences between CBS-corticobasal degeneration and CBS-Alzheimer's disease","volume":"25","author":"Josephs","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2019.01.046_bb0145","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/mds.25746","article-title":"Pathology and sensitivity of current clinical criteria in corticobasal syndrome","volume":"29","author":"Ouchi","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2019.01.046_bb0150","doi-asserted-by":"crossref","DOI":"10.1001\/archneurol.2008.596","article-title":"Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain","author":"Tapiola","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2019.01.046_bb0155","doi-asserted-by":"crossref","DOI":"10.1007\/s00702-007-0629-4","article-title":"Tauopathies and synucleinopathies: do cerebrospinal fluid \u03b2-amyloid peptides reflect disease-specific pathogenesis?","author":"Mollenhauer","year":"2007","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jns.2019.01.046_bb0160","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2014-309562","article-title":"A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes","author":"Magdalinou","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.01.046_bb0165","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archneurol.2012.1654","article-title":"Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and\/or parkinsonian disorders","volume":"69","author":"Hall","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2019.01.046_bb0170","doi-asserted-by":"crossref","DOI":"10.1001\/archneur.61.10.1579","article-title":"Apolipoprotein e \u03b54 is a determinant for Alzheimer-type pathologic features in tauopathies, synucleinopathies, and frontotemporal degeneration","author":"Josephs","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2019.01.046_bb0175","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000478979","article-title":"Cerebrospinal fluid TAR DNA-binding protein 43 combined with tau proteins as a candidate biomarker for amyotrophic lateral sclerosis and frontotemporal dementia spectrum disorders","volume":"44","author":"Bourbouli","year":"2017","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.jns.2019.01.046_bb0180","doi-asserted-by":"crossref","DOI":"10.1111\/j.1471-4159.2012.07911.x","article-title":"Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies","author":"Luk","year":"2012","journal-title":"J. Neurochem."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19300565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19300565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T21:16:24Z","timestamp":1550870184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X19300565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":36,"alternative-id":["S0022510X19300565"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2019.01.046","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical, neuropsychological and imaging characteristics of Alzheimer's disease patients presenting as corticobasal syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2019.01.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}